Vanhoutte Leen, Nogueira Daniela, Gerris Jan, Dhont Marc, De Sutter Petra
Infertility Centre, Ghent University Hospital, Ghent, Belgium.
Mol Reprod Dev. 2008 Jun;75(6):1021-30. doi: 10.1002/mrd.20851.
The present study aimed to analyze detailed morphological and functional characteristics of mouse in vitro matured oocytes after a pre-maturation culture (PMC) by temporary nuclear arrest with the specific phosphodiesterase 3-inhibitor (PDE3-I) Cilostamide. In a first experiment the lowest effective dose of Cilostamide was determined. Cumulus-oocyte complexes (COCs), isolated from small antral follicles, were exposed to different concentrations of Cilostamide (ranging from 0 (control) to 10 microM) for 24 hr. Afterwards, oocytes were removed from PDE3-I-containing medium and underwent in vitro maturation (IVM) for 16-18 hr. A concentration of 1 microM Cilostamide was the lowest effective dose for maximum level of inhibition and reversibility of meiosis inhibition. This concentration was used in further experiments to evaluate oocyte quality following IVM in relation to different parameters: kinetics of meiotic progression, metaphase II (MII) spindle morphology, aneuploidy rate, fertilization, and embryonic developmental rates. The results were compared to nonarrested (in vitro control) and in vivo matured oocytes (in vivo control). Following withdrawal of the inhibitor, the progression of meiosis was more synchronous and accelerated in arrested when compared to nonarrested oocytes. A PMC resulted in a significant increase in the number of oocytes constituting a MII spindle of normal morphology. None of the oocytes exposed to PDE3-I showed numerical chromosome alterations. In addition, fertilization and embryonic developmental rates were higher in the PMC group compared to in vitro controls, but lower than in vivo controls. These results provide evidence that induced nuclear arrest by PDE3-I is a safe and reliable method to improve oocyte quality after IVM.
本研究旨在分析用特异性磷酸二酯酶3抑制剂(PDE3-I)西洛他唑通过暂时核阻滞进行预成熟培养(PMC)后,小鼠体外成熟卵母细胞的详细形态和功能特征。在第一个实验中,确定了西洛他唑的最低有效剂量。从小窦卵泡中分离出的卵丘-卵母细胞复合体(COC)暴露于不同浓度的西洛他唑(范围从0(对照)到10微摩尔)24小时。之后,将卵母细胞从含PDE3-I的培养基中取出,进行16 - 18小时的体外成熟(IVM)。1微摩尔浓度的西洛他唑是减数分裂抑制的最大抑制水平和可逆性的最低有效剂量。在进一步的实验中使用该浓度来评估IVM后卵母细胞质量与不同参数的关系:减数分裂进程动力学、中期II(MII)纺锤体形态、非整倍体率、受精率和胚胎发育率。将结果与未阻滞(体外对照)和体内成熟卵母细胞(体内对照)进行比较。去除抑制剂后,与未阻滞的卵母细胞相比,阻滞的卵母细胞减数分裂进程更同步且加速。PMC导致构成正常形态MII纺锤体的卵母细胞数量显著增加。暴露于PDE3-I的卵母细胞均未显示染色体数目改变。此外,与体外对照相比,PMC组的受精率和胚胎发育率更高,但低于体内对照。这些结果提供了证据,表明PDE3-I诱导的核阻滞是一种安全可靠的方法,可改善IVM后卵母细胞的质量。